On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Warning Letter to Platinum Biologics LLC for marketing umbilicalcordderived products including exosome products (NanoEx & Nano Xsomes) without approval. BPC TB 5 Beverly Hills Rejuvenation Center FDA Issues Warning Letters Against Online GLP 1 Sellers BioSpace What are peptides? The treatments promising weight loss and better skin, explained Vox DOJ & FDA Vape Raids: Impact on Retailers & Distributors Token of Trust FDA issues warning about dietary additive 7 OH